Tower Research Capital LLC (Trc) Geron Corp Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Geron Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 131,956 shares of GERN stock, worth $240,159. This represents 0.01% of its overall portfolio holdings.
Number of Shares
131,956
Previous 10,027
1216.01%
Holding current value
$240,159
Previous $45,000
937.78%
% of portfolio
0.01%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding GERN
# of Institutions
307Shares Held
465MCall Options Held
1.07MPut Options Held
648K-
Black Rock Inc. New York, NY46.6MShares$84.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$61 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$54.6 Million1.72% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$49.6 Million18.81% of portfolio
-
State Street Corp Boston, MA27.2MShares$49.4 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $688M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...